amodiaquine has been researched along with Diabetic Nephropathies in 1 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, HY | 1 |
| Kang, JM | 1 |
| Jun, HH | 1 |
| Kim, DJ | 1 |
| Park, SH | 1 |
| Sung, MJ | 1 |
| Heo, JH | 1 |
| Yang, DH | 1 |
| Lee, SH | 1 |
| Lee, SY | 1 |
1 other study available for amodiaquine and Diabetic Nephropathies
| Article | Year |
|---|---|
Chloroquine and amodiaquine enhance AMPK phosphorylation and improve mitochondrial fragmentation in diabetic tubulopathy.
Topics: Amodiaquine; AMP-Activated Protein Kinases; Animals; Antimalarials; Cell Line; Chloroquine; Diabetes | 2018 |